Primary hyperaldosteronism and its relationship with arterial hypertension. Systematic review [Hiperaldosteronismo primario y su relación con la hipertensión arterial. Revisión sistemática]
DOI:
https://doi.org/10.62574/vhx78f58Keywords:
blood pressure, blood pressure determination, central venous pressureAbstract
Objective: to describe primary hyperaldosteronism and its relationship with arterial hypertension. Method: Systematic review. Results and conclusion: Primary hyperaldosteronism (PHA) constitutes a relevant aetiology of secondary arterial hypertension, particularly in young patients, whose timely identification is essential to mitigate the risk of long-term cardiovascular and renal complications. Despite advances in diagnostic techniques, such as adrenal venous sampling and genetic characterisation, their clinical application faces limitations related to accessibility, technical complexity and costs.
Downloads
References
Jin Y, Qiu W, Yao J. A case report of a young boy with low renin and high aldosterone levels induced by Liddle syndrome who was previously misdiagnosed with primary aldosteronism. J Pediatr Endocrinol Metab. 2022;36(2):212-215. Published 2022 Dec 6. doi:10.1515/jpem-2022-0194
Gilani M, Asif N, Akram A, Gilani M, Ijaz A, Malik SS. Spectrum of renin angiotensin aldosterone system disorders in young hypertensives. J Pak Med Assoc. 2018;68(8):1179-1182.
Gilani M, Asif N, Nawaz A, Akram A. Frequency of Primary Hyperaldosteronism in Young Hypertensives in a Tertiary Care Setting of Rawalpindi. J Coll Physicians Surg Pak. 2019;29(1):58-61. doi:10.29271/jcpsp.2019.01.58
Cui Q, Lu J, Zhang C, Tan S. Diagnostic challenges and good treatment outcomes in pediatric paraganglioma of the abdomen: A case report. Medicine (Baltimore). 2018;97(47):e13268. doi:10.1097/MD.0000000000013268
Jędrusik P, Symonides B, Wojciechowska E, Gryglas A, Gaciong Z. Diagnostic value of potassium level in a spot urine sample as an index of 24-hour urinary potassium excretion in unselected patients hospitalized in a hypertension unit. PLoS One. 2017;12(6):e0180117. Published 2017 Jun 29. doi:10.1371/journal.pone.0180117
Yang S, Du Z, Zhang X, et al. Corticotropin Stimulation in Adrenal Venous Sampling for Patients With Primary Aldosteronism: The ADOPA Randomized Clinical Trial. JAMA Netw Open. 2023;6(10):e2338209. Published 2023 Oct 2. doi:10.1001/jamanetworkopen.2023.38209
García-Castaño A, Gómez-Conde S, Gondra L, et al. Genotypic variability in patients with clinical diagnosis of Bartter syndrome type 3. Sci Rep. 2023;13(1):12587. Published 2023 Aug 3. doi:10.1038/s41598-023-38179-6
Palazzo V, Raglianti V, Landini S, et al. Clinical and Genetic Characterization of Patients with Bartter and Gitelman Syndrome. Int J Mol Sci. 2022;23(10):5641. Published 2022 May 18. doi:10.3390/ijms23105641
Zennaro MC, Jeunemaitre X. SFE/SFHTA/AFCE consensus on primary aldosteronism, part 5: Genetic diagnosis of primary aldosteronism. Ann Endocrinol (Paris). 2016;77(3):214-219. doi:10.1016/j.ando.2016.02.006
Kotanidou EP, Giza S, Tsinopoulou VR, Vogiatzi M, Galli-Tsinopoulou A. Diagnosis and Management of Endocrine Hypertension in Children and Adolescents. Curr Pharm Des. 2020;26(43):5591-5608. doi:10.2174/1381612826666201113103614
Kietsiriroje N, Wonghirundecha R, Suntornlohanakul O, Murray RD. Construction of a predictive scoring system as a guide to screening and confirmation of the diagnosis of primary aldosteronism. Clin Endocrinol (Oxf). 2020;92(3):196-205. doi:10.1111/cen.14142
Guo Z, Poglitsch M, McWhinney BC, et al. Measurement of Equilibrium Angiotensin II in the Diagnosis of Primary Aldosteronism. Clin Chem. 2020;66(3):483-492. doi:10.1093/clinchem/hvaa001
Tan ST, Boyle V, Elston MS. Systematic Review of Therapeutic Agents and Long-Term Outcomes of Familial Hyperaldosteronism Type 1. Hypertension. 2023;80(7):1517-1525. doi:10.1161/HYPERTENSIONAHA.123.21054
de Freminville JB, Gardini M, Cremer A, et al. Prevalence and Risk Factors for Secondary Hypertension in Young Adults. Hypertension. 2024;81(11):2340-2349. doi:10.1161/HYPERTENSIONAHA.124.22753
Mantoo MR, Kabra M, Kabra SK. Cystic Fibrosis Presenting as Pseudo-Bartter Syndrome: An Important Diagnosis that is Missed!. Indian J Pediatr. 2020;87(9):726-732. doi:10.1007/s12098-020-03342-8
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Carlos Gustavo López-Barrionuevo , Karen Daniela Salazar-Pullutacsi, Gabriela Alexandra Villacis-Paredes
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
CC BY-NC-SA : Esta licencia permite a los reutilizadores distribuir, remezclar, adaptar y construir sobre el material en cualquier medio o formato solo con fines no comerciales, y solo siempre y cuando se dé la atribución al creador. Si remezcla, adapta o construye sobre el material, debe licenciar el material modificado bajo términos idénticos.
